【摘要】 目的 利用评估工具，分析新冠肺炎疫情背景下北京市三级医疗机构传染病防控资源投入的社会和经济效益情况。方法 结合现场调查数据和文献研究参数，测算医疗机构传染病防控资源投入的成本及效益，并利用卫生经济学方法对经济效益进行成本效益及敏感性分析。结果 与2019年相比，2020年和2021年样本医疗机构传染病防控新增投入分别为242 115 110万元和187 236 171万元，传染病防控能力大幅提升，避免的健康相关经济损失分别为4 434.5万元和104.5万元，效益成本比分别为1∶5.46和1∶179.25。敏感性分析显示，2020年和2021年，当全人群新冠肺炎感染者比例分别大于0.025%和0.183%时，现有成本投入下的效益成本比大于1。结论 医疗机构传染病防控投入产生了良好的社会效益。在现有人群感染率水平下，不具有明显的经济效益；在现有成本投入下，人群感染率水平越高，经济效益越明显。更多还原

【Abstract】 Objective To evaluate the social and economic benefits of investment in infectious disease prevention and control of medical institutions in Beijing under the COVID-19 epidemic. Methods The field survey data and literature research parameters are used to calculate the input and output of infectious disease prevention and control resources,and the method of health economics is used to conduct the cost-benefit analysis and sensitivity analysis.Results Compared with 2019, the increased input of the sample hospitals for infectious disease prevention and control is 242.115 million yuan in 2020 and 187.236 million yuan in 2021. The infectious disease prevention and control ability of sample hospitals is greatly improved. The avoided health-related economic losses are 44.345 million yuan and 1.045 million yuan respectively,and the benefit-cost ratio is 1:5.46 and 1:179.25 respectively. Conclusion The input in infectious disease prevention and control of medical institutions had achieved good social benefits,but it was no obvious economic benefits under the current infection level. Under the level of existing cost input, the economic benefit would be more obvious at a higher infection rate in the population.更多还原